Fig. 1 | Scientific Reports

Fig. 1

From: Distinct cardiac troponin alterations in patients with cocaine and alcohol use disorders during abstinence for cardiovascular risk assessment

Fig. 1

Plasma concentrations of cTnT and cTnI in the sample based on primary substance use disorder or cardiovascular disease diagnosis. (a) Bars represent estimated marginal means and 95% CI of back-transformed values from log (10)-transformed cTnT concentrations (pg/mL), based on primary substance use disorder; (b) Bars represent estimated marginal means and 95% CI of back-transformed values from log (10)-transformed cTnI concentrations (pg/mL), based on primary substance use disorder; (c) Bars represent estimated marginal means and 95% CI of back-transformed values from log (10)-transformed cTnT concentrations (pg/mL), based on cardiovascular disease diagnosis; (d) Bars represent estimated marginal means and 95% CI of back-transformed values from log (10)-transformed cTnI concentrations (pg/ml), based on cardiovascular disease diagnosis. (*) indicates p < 0.05 compared to the control group; (**) indicates p < 0.01 compared to the control group; and (***) indicates p < 0.001 compared to the control group. (a) and (b) were analyzed using a one-way ANCOVA with primary substance use disorder as the factor, controlling for age, BMI, and sex; (c) and (d) were analyzed using a one-way ANCOVA with cardiovascular disease diagnosis as the factor, controlling for age, BMI, and sex.

Back to article page